Literature DB >> 28646969

Things that could be Mycoplasma pneumoniae.

Ruben C A de Groot1, Patrick M Meyer Sauteur2, Wendy W J Unger3, Annemarie M C van Rossum4.   

Abstract

M. pneumoniae infection gives rise to a wide variety of manifestations. The pathogenesis of secondary manifestations is not always known. Some depend on the direct invasion of M. pneumoniae and others on the indirect effect of M. pneumoniae through pathological immune responses, for instance autoreactive antibodies in Guillain-Barré Syndrome. Diagnosis remains challenging with currently available diagnostic tests, because they do not demonstrate a causal relation due to M. pneumoniae asymptomatic carriage or previous infection. The mainstay of treatment is macrolide antibiotics, but the role of additional immunomodulation therapy is unclear. Knowledge of the pathogenesis of the different manifestations should guide strategies for diagnosis and treatment.
© 2017 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cold agglutinin disease; Encephalitis; Guillain-Barré syndrome; Infectious arthritis; Macrolides; Mycoplasma pneumoniae; Respiratory tract diseases; Serological test; Stevens-Johnson syndrome

Mesh:

Substances:

Year:  2017        PMID: 28646969     DOI: 10.1016/S0163-4453(17)30198-6

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  12 in total

1.  Mycoplasma pneumoniae Compared to Streptococcus pneumoniae Avoids Induction of Proinflammatory Epithelial Cell Responses despite Robustly Inducing TLR2 Signaling.

Authors:  R C A de Groot; H Zhu; T Hoogenboezem; A C J M de Bruijn; E Eenjes; A E J 't Jong; A I Belo; S C Estevão; J J Bajramovic; R J Rottier; M Kool; A M C van Rossum; W W J Unger
Journal:  Infect Immun       Date:  2022-07-11       Impact factor: 3.609

2.  Clinical efficacy enhancement of a Chinese herbal injection in the treatment of mycoplasma pneumonia in children: A protocol of randomized controlled trial.

Authors:  Mian Wang; Hongying Li; Jialing Yang; Meng Wang; Jie Liu
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

Review 3.  Pathogenesis and Treatment of Neurologic Diseases Associated With Mycoplasma pneumoniae Infection.

Authors:  Renato D'Alonzo; Elisabetta Mencaroni; Lorenza Di Genova; Daniela Laino; Nicola Principi; Susanna Esposito
Journal:  Front Microbiol       Date:  2018-11-20       Impact factor: 5.640

Review 4.  Pharmacotherapy of Lower Respiratory Tract Infections in Elderly-Focused on Antibiotics.

Authors:  Yang Liu; Yan Zhang; Wanyu Zhao; Xiaolei Liu; Fengjuan Hu; Birong Dong
Journal:  Front Pharmacol       Date:  2019-10-31       Impact factor: 5.810

Review 5.  Comparative efficacy of Chinese herbal injections combined with azithromycin for mycoplasma pneumonia in children: A Bayesian network meta-analysis of randomized controlled trials.

Authors:  Xiaojiao Duan; Kaihuan Wang; Jiarui Wu; Dan Zhang; Xinkui Liu; Mengwei Ni; Shuyu Liu; Ziqi Meng
Journal:  J Clin Pharm Ther       Date:  2019-05-22       Impact factor: 2.512

6.  A 21-Year-Old Immunocompetent Man With Hemoptysis and Rash.

Authors:  Aslam Abbasi Akhtar; Albert Samost; Kendrew Wong; Ammar Alhaddad; Guillermo Gutierrez
Journal:  Chest       Date:  2020-10       Impact factor: 9.410

7.  The clinical characteristics of Mycoplasma pneumoniae pneumonia and its relationship between hypokalemia in west China.

Authors:  Zhoubo Han; Yong Zhang; Shunli Liao; Na Zhou
Journal:  Transl Pediatr       Date:  2021-02

Review 8.  Mycoplasma pneumoniae Infections: Pathogenesis and Vaccine Development.

Authors:  Zhulin Jiang; Shuihong Li; Cuiming Zhu; Runjie Zhou; Polly H M Leung
Journal:  Pathogens       Date:  2021-01-25

9.  Stevens-Johnson Syndrome and Stroke Related to Mycoplasma.

Authors:  Sanjay K Yadava; Soumya Adhikari; Niranjan Ojha; Syed Hammad Zaidi; Jain Hanish; Tasaduq Fazili
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

10.  Early prediction of necrotizing pneumonia from mycoplasma pneumoniae pneumonia with large pulmonary lesions in children.

Authors:  Yunlian Zhou; Mengting Hu; Bei Ye; Zhimin Chen; Yuanyuan Zhang
Journal:  Sci Rep       Date:  2020-11-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.